Merit Medical Systems | MMSI - 流动负债



金融业
股票价格
USD
资产
USD 2.69B
现金及等价物
USD 446.4M
销售成本
USD 198.58M
流动资产
USD 1.04B
流动负债
USD 239.76M
债务
USD 821.15M
EBIT
USD 54.2M
EBITDA
USD 97.23M
员工
7.4K
EPS每股收益
USD 1.04
股本和储备
USD 1.58B
销售毛利
USD 195.35M
债务利息支出
USD 6.36M
利息收入
USD 3.62M
贷款资金
USD 734.04M
市值
USD 4.05B
净收入
USD 27.76M
营业费用
USD 339.74M
营业利润
USD 54.2M
普通股股本
USD 59.29M
PE价格收益
39.13
税前利润
USD 73.18M
销售收入
USD 393.9M
销售和管理费用
USD 114.83M
股票
USD 333.71M
贸易债权人
USD 60.55M
应收帐款人
USD 223.61M


流动负债 更改 日
3M USD 9.6B 862M 2025-12
Abbott USD 16.5B 1.91B 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Anika Therapeutics USD 21.91M 2.82M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Globus Medical USD 498.5M 32.54M 2025-12
Haemonetics USD 539.87M 8.45M 2025-12
Hologic USD 951.3M 25.9M 2025-12
ICU Medical USD 498.86M 5.96M 2025-12
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
J&J USD 54.13B 3.26B 2025-12
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Olympus JPY 400.73B 106.59B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
STAAR Surgical USD 68.5M 6.87M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 19.44M 1.1M 2025-06
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Terumo JPY 539.7B 243.4B 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12